RADIATION THERAPY ONCOLOGY GROUP
RTOG 0913
PHASE I/II TRIAL OF CONCURRENT RAD001 (EVEROLIMUS) WITH TEMOZOLOMIDE/RADIATION FOLLOWED BY ADJUVANT RAD001/TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA
RTOG 0913
PHASE I/II TRIAL OF CONCURRENT RAD001 (EVEROLIMUS) WITH TEMOZOLOMIDE/RADIATION FOLLOWED BY ADJUVANT RAD001/TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA
Protocol Participation Information
- Credentialing
- Credentialing Requirements
- Facility Questionnaire: Part I is required for this protocol.
- How to Participate
- Digital Data Submission Procedures
- Digital Data Submission Information (DDSI) Form
- Data Submission Check list
- ATC Compliant Treatment Planning Systems
- Structure Names
- Protocol Text (pre-activation revision 10-14-10)
Back to protocols
